Fundraising FoxPahrtx
3 known investors
Find your way into Pahrtx
Sign up to see every warm intro you have to Pahrtx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Pahrtx team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
PAhR Therapeutics is a clinical-stage biotech company developing novel mechanisms to treat pulmonary arterial hypertension (PAH).
Investors · 3
AN Venture Partners✓ confirmed by PahrtxTokyo
How we know: the company's own site · the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Pahrtx do?
- PAhR Therapeutics is a clinical-stage biotech company developing novel mechanisms to treat pulmonary arterial hypertension (PAH).
- Who are Pahrtx's investors?
- Pahrtx's investors include AN Venture Partners, RA Capital, UTEC.